Suppr超能文献

系统免疫水平决定肺癌软脑膜转移的预后

Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer.

作者信息

Hong Ye, Duan Ping, He Lang, Li Qing, Chen Yueyun, Wang Peipei, Fu Yang, Liu Ting, Ding Zhenyu

机构信息

Department of Biotherapy, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.

Department of Oncology, Cheng Du First People's Hospital, Chengdu, People's Republic of China.

出版信息

Cancer Manag Res. 2022 Mar 15;14:1153-1164. doi: 10.2147/CMAR.S347323. eCollection 2022.

Abstract

BACKGROUND AND PURPOSE

Leptomeningeal metastases (LM) is the end-event of lung cancer and the prognosis is dismal. Few studies explored the prognostic performance of systematic immunological levels in lung cancer patients with LM. Our study aimed to explore the possible relationship between the prognosis of LM and systematic immunological level and other clinical characteristics.

METHODS

This retrospective, multi-institutional, observational study was conducted in 4 tertiary centers in China. Patients were screened from January 2009 to May 2019. Patients with radiographically or histologically confirmed LM were enrolled. The data of systematic immunological level and other clinical characteristics of each patient were extracted and statistically analyzed to establish a prognostic model based on statistical analysis results. The predictive accuracy and discriminative capability of the model were evaluated by the calibration curve and concordance index (C-index).

RESULTS

A total of 109 patients were enrolled in the study. Patients with adenocarcinoma, tumors harboring EGFR mutation, at their age of 50-59, with either bone, brain, or lung metastases, were enriched in this cohort. The median overall survival (OS) was 20.4 months (95% CI: 15.2-25.6). Cox univariate and multivariate analysis revealed better PS (0-1), no distant lymph nodes metastasis (DLNM), simultaneous diagnosis of lung cancer and leptomeningeal metastasis (SDLL), and lower neutrophil to lymphocyte ratio (NLR), were associated with better OS. Based on these independent prognostic variables, a prognostic nomogram model with a C-index for OS prediction of 0.71, was constructed. The actual probability of survival at 1-, 2- and 3-year showed good concordance with the prediction curve of our nomogram.

CONCLUSION

The systematic immunological level was an independent prognostic factor of lung cancer patients with LM. The prognostic model based on statistical analysis had a good ability to predict the OS of patients.

摘要

背景与目的

软脑膜转移(LM)是肺癌的终末期事件,预后不佳。很少有研究探讨系统性免疫水平在肺癌合并LM患者中的预后价值。本研究旨在探讨LM预后与系统性免疫水平及其他临床特征之间的可能关系。

方法

本回顾性、多机构、观察性研究在中国4家三级中心进行。筛选2009年1月至2019年5月期间的患者。纳入经影像学或组织学确诊为LM的患者。提取每位患者的系统性免疫水平及其他临床特征数据并进行统计分析,根据统计分析结果建立预后模型。通过校准曲线和一致性指数(C指数)评估模型的预测准确性和鉴别能力。

结果

共纳入109例患者。该队列中腺癌患者、携带EGFR突变的肿瘤患者、年龄在50 - 59岁、有骨、脑或肺转移的患者较多。中位总生存期(OS)为20.4个月(95%CI:15.2 - 25.6)。Cox单因素和多因素分析显示,较好的体能状态(0 - 1)、无远处淋巴结转移(DLNM)、肺癌与软脑膜转移同时诊断(SDLL)以及较低的中性粒细胞与淋巴细胞比值(NLR)与较好的OS相关。基于这些独立预后变量,构建了OS预测C指数为0.71的预后列线图模型。1年、2年和3年的实际生存概率与我们列线图的预测曲线显示出良好的一致性。

结论

系统性免疫水平是肺癌合并LM患者的独立预后因素。基于统计分析的预后模型对患者的OS具有良好的预测能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca1f/8934871/efdbf3218716/CMAR-14-1153-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验